KC Pharma

KC Pharma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $47M

Overview

KC Pharma is a dominant, revenue-generating private label contract manufacturer specializing in OTC eye care products. It serves 26 of the top 30 US retailers, distributing to over 90,000 stores through a network of 200+ distribution centers from its 150,000-square-foot campus. The company leverages over 35 years of aseptic manufacturing expertise, a dedicated R&D team, and a strategic partnership with a world-class company to maintain its market leadership and first-to-market capabilities. Its business model is built on providing high-quality, affordable drug products and medical devices with a strong service orientation.

Ophthalmology

Technology Platform

Specialized aseptic fill manufacturing and formulation expertise for sterile ophthalmic solutions, supported by an FDA-inspected facility, state-of-the-art equipment, and an in-house R&D team focused on private label product development.

Funding History

2
Total raised:$47M
Series B$32M
Series A$15M

Opportunities

The company is poised to benefit from the sustained growth of the private label segment in consumer healthcare.
Opportunities include deepening penetration with existing retail customers, expanding into adjacent OTC product categories using its aseptic manufacturing expertise, and potentially exploring geographic expansion or contract manufacturing for branded clients.

Risk Factors

Key risks include high customer concentration among a few large retailers, regulatory compliance risks associated with FDA-inspected aseptic manufacturing, competitive margin pressure from other contract manufacturers, and vulnerabilities in the global supply chain for raw materials.

Competitive Landscape

KC Pharma competes in the private label contract manufacturing space, facing competition from other specialized CMOs and large generic pharmaceutical companies with manufacturing divisions. Its primary competitive advantages are its scale, dedicated focus on eye care, over 35 years of aseptic expertise, and its entrenched relationships with major North American retailers.